1. Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1 data from the KEYNOTE-659 phase IIb study. (April 2020) Authors: Kawazoe, Akihito; Yamaguchi, Kensei; Yasui, Hisateru; Negoro, Yuji; Azuma, Mizutomo; Amagai, Kenji; Hara, Hiroki; Baba, Hideo; Tsuda, Masahiro; Hosaka, Hisashi; Kawakami, Hisato; Oshima, Takashi; Omuro, Yasushi; Machida, Nozomu; Esaki, Taito; Yoshida, Kazuhiro; Nishina, Tomohiro; Komatsu, Yoshito... Journal: European journal of cancer Issue: Volume 129(2020) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗